Links between accelerated replicative cellular senescence and down-regulation of SPHK1 transcription
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We have identified a mechanism to diminish the proliferative capacity of cells during cell expansion using human adiposederived stromal cells (hAD-SCs) as a model of replicative senescence. hAD-SCs of high-passage numbers exhibited a reduced proliferative capacity with accelerated cellular senescence. Levels of key bioactive sphingolipids were significantly increased in these senescent hAD-SCs. Notably, the transcription of sphingosine kinase 1 (SPHK1) was down-regulated in hAD-SCs at high-passage numbers. SPHK1 knockdown as well as inhibition of its enzymatic activity impeded the proliferation of hAD-SCs, with concomitant induction of cellular senescence and accumulation of sphingolipids, as seen in high-passage cells. SPHK1 knockdown-accelerated cellular senescence was attenuated by co-treatment with sphingosine-1-phosphate and an inhibitor of ceramide synthesis, fumonisin B1, but not by treatment with either one alone. Together, these results suggest that transcriptional down-regulation of SPHK1 is a critical inducer of altered sphingolipid profiles and enhances replicative senescence during multiple rounds of cell division.
Abstract
We have identified a mechanism to diminish the proliferative capacity of cells during cell expansion using human adiposederived stromal cells (hAD-SCs) as a model of replicative senescence. hAD-SCs of high-passage numbers exhibited a reduced proliferative capacity with accelerated cellular senescence. Levels of key bioactive sphingolipids were significantly increased in these senescent hAD-SCs. Notably, the transcription of sphingosine kinase 1 (SPHK1) was down-regulated in hAD-SCs at high-passage numbers. SPHK1 knockdown as well as inhibition of its enzymatic activity impeded the proliferation of hAD-SCs, with concomitant induction of cellular senescence and accumulation of sphingolipids, as seen in high-passage cells. SPHK1 knockdown-accelerated cellular senescence was attenuated by co-treatment with sphingosine-1-phosphate and an inhibitor of ceramide synthesis, fumonisin B1, but not by treatment with either one alone. Together, these results suggest that transcriptional down-regulation of SPHK1 is a critical inducer of altered sphingolipid profiles and enhances replicative senescence during multiple rounds of cell division.
참고문헌 (30)
- Goni FM, "Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids", Biochim Biophys Acta, 1758, pp.1902~1921 (2006)
- Hannun YA, "Principles of bioactive lipid signalling : lessons from sphingolipids", Nat Rev Mol Cell Biol, 9, pp.139~150 (2008)
- Adada M, "Inhibitors of the sphingomyelin cycle : Sphingomyelin synthases and sphingomyelinases", Chem Phys Lipids, 197, pp.45~59 (2016)
- Hernandez-Corbacho MJ, "Sphingolipids in mitochondria", Biochim Biophys Acta Mol Cell Biol Lipids, 1862, pp.56~68 (2017)
- Venable ME, "Role of ceramide in cellular senescence", J Biol Chem, 270, pp.30701~30708 (1995)
- Kolesnick RN, "Compartmentalization of ceramide signaling : physical foundations and biological effects", J Cell Physiol, 184, pp.285~300 (2000)
- Zhang H, "Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation", J Cell Biol, 114, pp.155~167 (1991)
- Trayssac M, "Role of sphingolipids in senescence : implication in aging and age-related diseases", J Clin Invest, 128, pp.2702~2712 (2018)
- Campisi J, "The biology of replicative senescence", Eur J Cancer, 33, pp.703~709 (1997)
- Hayflick L, "The serial cultivation of human diploid cell strains", Exp Cell Res, 25, pp.585~621 (1961)
- Flatt T, "A new definition of aging?", Front Genet, 3, pp.148~ (2012)
- Sherr CJ, "Cellular senescence:mitotic clock or culture shock?", Cell, 102, pp.407~410 (2000)
- Michaloglou C, "BRAFE600-associated senescence-like cell cycle arrest of human naevi", Nature, 436, pp.720~724 (2005)
- Chen QM, "Uncoupling the senescent phenotype from telomere shortening in hydrogen peroxide-treated fibroblasts", Exp Cell Res, 265, pp.294~303 (2001)
- Lowe SW, "Intrinsic tumour suppression", Nature, 432, pp.307~315 (2004)
- Serrano M, "Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a", Cell, 88, pp.593~602 (1997)
- Stein GH, "Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts", Science, 249, pp.666~669 (1990)
- Wei W, "Role of p14(ARF)in replicative and induced senescence of human fibroblasts", Mol Cell Biol, 21, pp.6748~6757 (2001)
- Vadas M, "The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction?", Biochim Biophys Acta, 1781, pp.442~447 (2008)
- Meng H, "Loss of sphingosine kinase 1", S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia, 2011, pp.6, e27150~
- Spiegel S, "Sphingosine-1-phosphate : an enigmatic signalling lipid", Nat Rev Mol Cell Biol, 4, pp.397~407 (2003)
- Taha TA, "Loss of sphingosine kinase-1activates the intrinsic pathway of programmed cell death : modulation of sphingolipid levels and the induction of apoptosis", FASEB J, 20, pp.482~484 (2006)
- Bartke N and Hannun YA, "Bioactive sphingolipids:metabolism and function", J Lipid Res, 50, pp.S91~S96 (2009)
- Johnson KR, "Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue", J Histochem Cytochem, 53, pp.1159~1166 (2005)
- Xia P, "An oncogenic role of sphingosine kinase", Curr Biol, 10, pp.1527~1530 (2000)
- Olivera A, "Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival", J Cell Biol, 147, pp.545~558 (1999)
- Le Stunff H, "Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis", J Cell Biol, 158, pp.1039~1049 (2002)
- Heffernan-Stroud LA, "Defining a role for sphingosine kinase 1 in p53-dependent tumors", Oncogene, 31, pp.1166~1175 (2012)
- Taha TA, "Downregulation of sphingosine kinase-1 by DNA damage : dependence on proteases and p53", J Biol Chem, 279, pp.20546~20554 (2004)
- He Q, "Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver", Toxicol Sci, 94, pp.388~397 (2006)